Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study
Open Access
- 11 June 2024
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (6) , e29728
Abstract
Since May 2022, several countries outside of Africa experienced multiple clusters of monkeypox virus (MPXV)‐associated disease. In the present study, anti‐MPXV and anti‐vaccinia virus (VACV) neutralizing antibody responses were evaluated in two cohorts of subjects from the general Italian population (one half born before the WHO‐recommended end of smallpox vaccination in 1980, the other half born after). Higher titers (either against MPXV or VACV) were observed in the cohort of individuals born before the interruption of VACV vaccination. An association between VACV and MPXV antibody levels was observed, suggesting that the smallpox vaccination may confer some degree of cross‐protection against MPXV infection. Results from this study highlight low levels of immunity toward the assessed Orthopoxviruses, especially in young adults, advocating the introduction of a VACV‐ or MPXV‐specific vaccine in case of resurgence of monkeypox disease outbreaks.Keywords
This publication has 21 references indexed in Scilit:
- Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individualsNature Medicine, 2022
- Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022New England Journal of Medicine, 2022
- The WHO Declaration of Monkeypox as a Global Public Health EmergencyJAMA, 2022
- Monkeypox virus: a re-emergent threat to humansVirologica Sinica, 2022
- Understanding orthopoxvirus host range and evolution: from the enigmatic to the usual suspectsCurrent Opinion in Virology, 2018
- Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsCell, 2016
- Clinical Manifestations of Human Monkeypox Influenced by Route of InfectionThe Journal of Infectious Diseases, 2006
- Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virusNature Medicine, 2005
- Monkeypox: A review of the history and emergence in the Western hemisphereSeminars in Pediatric Infectious Diseases, 2004
- Nucleotide sequence comparison of homologous genomic regions from variola, monkeypox, and vaccinia virusesJournal of Medical Virology, 1990